Disappointed by the revenue, when are all our esteemed international 'partners' going to start paying for what we do for them. I thought completion of the last POC1 study/project was meant to net $250,000 per scientist?
Having said that, the future is beginning to look more exciting than ever with a reasonable cash runway to realise cashflow positive operations.
Also no mention of acquisition developments - or did I scan read it too quickly?
ADO Price at posting:
9.3¢ Sentiment: Hold Disclosure: Held
